Sign Up Today and Learn More About Tia Stock
Invest in or calculate the value of your shares in Tia or other pre-IPO companies through EquityZen's platform.

Tia Stock (TIA)
Enable every person to achieve their own definition of optimal health through science-backed information, access to high-quality care, and community.
About Tia Stock
Founded
2016
Headquarters
New York, NY, US
Industries
Blockchain and Crypto, Internet Services, Health Care
At Tia, we believe that the healthcare system was not built with women in mind. Today, considering that women control 80% of healthcare dollars in the U.S., Tia is seizing the opportunity to build a new, distinctly female model of care digitally and physically.Â
Tia Press Mentions
Stay in the know about the latest news on Tia
Hormone Therapy Market to Reach USD 41.97 Billion by 2035, Growing at 7.20% CAGR
globenewswire • Nov 19, 2025
Render CEO: How AI can map out better construction design
fierce-network • Nov 09, 2025
Tia Launches First-of-its-kind Hormone & Vitality Assessment for Women Beginning to Question Perimenopause or Noticing Shifts in Their Body
businesswire • Oct 29, 2025
Melinda French Gates-backed women's health startup Tia just cut 23% of its workforce
aol • Oct 29, 2025
Amazon leads October layoffs with 30,000 job cuts; Here are the major layoffs across tech, auto, and healthcare in October
economictimes • Oct 28, 2025
Investors in Tia
Discover investors in Tia stock and explore their portfolio companies
Tia Management
Leadership team at Tia
Co-Founder & COO
Felicity Yost
Co-Founder & CEO
Carolyn Witte

Join now and verify your accreditation status to gain access to:
- Tia Current Valuation
- Tia Stock Price
- Tia Management
- Available deals in Tia and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Tia Cap Table and Funding History by Share Class and Liquidity Preferences
- Tia Revenue and Financials
- Tia Highlights
- Tia Business Model
- Tia Risk Factors
- Tia Research Report from SACRA Research
Trading Tia Stock
How to invest in Tia stock?
Accredited investors can buy pre-IPO stock in companies like Tia through EquityZen funds. These investments are made available by existing Tia shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Tia stock?
Shareholders can sell their Tia stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 50K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."



